Fas ligand costimulates the in vivo proliferation of CD8+ T cells

被引:91
作者
Suzuki, I [1 ]
Martin, S [1 ]
Boursalian, TE [1 ]
Beers, C [1 ]
Fink, PJ [1 ]
机构
[1] Univ Washington, Dept Immunol, Seattle, WA 98195 USA
关键词
D O I
10.4049/jimmunol.165.10.5537
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Fas ligand (FasL/CD95L/APO-1L) is one of a growing number of TNF family members whose triggering costimulates maximal proliferation of activated T cells. In this study we show that maximal Ag-dependent accumulation of transferred TCR-transgenic CD8+ T cells requires Fas (CD95/APO-1) expression by the adoptive hosts. Additionally, adoptively transferred FasL(+) CD8(+) T cells demonstrate a 2-fold advantage in Ag-driven expansion over their Fast-counterparts. This study illustrates the in vivo role of TCR-dependent FasL costimulation In the Ag-specific proliferation of both heterogeneous and homogeneous populations of primary CD8+ T cells and long-term CTL lines. Thus, cross-linking FasL, on naive and Ag-experienced CD8+ T cells whose Ag-specific TCRs are engaged is required to drive maximal cellular proliferation in vivo.
引用
收藏
页码:5537 / 5543
页数:7
相关论文
共 30 条
  • [1] CRYSTAL-STRUCTURE OF THE SOLUBLE HUMAN 55 KD TNF RECEPTOR-HUMAN TNF-BETA COMPLEX - IMPLICATIONS FOR TNF RECEPTOR ACTIVATION
    BANNER, DW
    DARCY, A
    JANES, W
    GENTZ, R
    SCHOENFELD, HJ
    BROGER, C
    LOETSCHER, H
    LESSLAUER, W
    [J]. CELL, 1993, 73 (03) : 431 - 445
  • [2] MASSIVE UP-REGULATION OF THE FAS LIGAND IN LPR AND GLD MICE - IMPLICATIONS FOR FAS REGULATION AND THE GRAFT-VERSUS-HOST DISEASE-LIKE WASTING SYNDROME
    CHU, JL
    RAMOS, P
    ROSENDORFF, A
    NIKOLICZUGIC, J
    LACY, E
    MATSUZAWA, A
    ELKON, KB
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (01) : 393 - 398
  • [3] MOLECULAR PATHWAYS OF CTL-MEDIATED CYTOTOXICITY
    CLARK, WR
    WALSH, CM
    GLASS, AA
    HAYASHI, F
    MATLOUBIAN, M
    AHMED, R
    [J]. IMMUNOLOGICAL REVIEWS, 1995, 146 : 33 - 44
  • [4] DAILEY MO, 1985, J MOL CELL IMMUNOL, V2, P27
  • [5] ECK MJ, 1992, J BIOL CHEM, V267, P2119
  • [6] BOTH INTRATHYMIC AND PERIPHERAL SELECTION MODULATE THE DIFFERENTIAL EXPRESSION OF V-BETA-5 AMONG CD4+ AND CD8+ T-CELLS
    FINK, PJ
    SWAN, K
    TURK, G
    MOORE, MW
    CARBONE, FR
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (06) : 1733 - 1738
  • [7] Glass A, 1996, J IMMUNOL, V156, P3638
  • [8] TUMOR-NECROSIS-FACTOR LIGAND SUPERFAMILY - INVOLVEMENT IN THE PATHOLOGY OF MALIGNANT-LYMPHOMAS
    GRUSS, HJ
    DOWER, SK
    [J]. BLOOD, 1995, 85 (12) : 3378 - 3404
  • [9] T-CELL RECEPTOR ANTAGONIST PEPTIDES INDUCE POSITIVE SELECTION
    HOGQUIST, KA
    JAMESON, SC
    HEATH, WR
    HOWARD, JL
    BEVAN, MJ
    CARBONE, FR
    [J]. CELL, 1994, 76 (01) : 17 - 27
  • [10] CLONE-SPECIFIC T-CELL RECEPTOR ANTAGONISTS OF MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I RESTRICTED CYTOTOXIC T-CELLS
    JAMESON, SC
    CARBONE, FR
    BEVAN, MJ
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (06) : 1541 - 1550